Does the US patent system hold up or push forward the commercialization of technological innovations?
Does the US patent system frustrate or facilitate the inventive acivities and entrepreneurial processes central to economic growth?
Hoover IP² is working to review the premises of the US patent system and to address questions of scope, specification, duration, and economic impact of that system.
Recent Working Papers
IP² Working Paper No. 16002
First-Mover Advantages Before and After TRIPS: Evidence from the Indian Pharmaceutical Industry
by Ajay Bhaskarabhatla and Chirantan Chatterjee
IP² Working Paper No. 15018
The Market Impacts of Pharmaceutical Product Patents in Developing Countries
by Mark Duggan, Craig Garthwaite, and Aparajita Goyal
IP² Working Paper No.15017
Insider Trading and Innovation
by Ross Levine, Chen Lin and Lai Wei
IP² Working Paper No. 15014
Pushing Patent Boundaries:
An Empirical Assessment of How Patent Trolls and Other Litigants Use Patent Scope
by Janet Freilich